Logo image of NBR

NABORS INDUSTRIES LTD (NBR) Stock Fundamental Analysis

NYSE:NBR - New York Stock Exchange, Inc. - BMG6359F1370 - Common Stock - Currency: USD

32.61  -1.16 (-3.44%)

After market: 32.61 0 (0%)

Fundamental Rating

2

NBR gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 63 industry peers in the Energy Equipment & Services industry. Both the profitability and financial health of NBR have multiple concerns. NBR is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

NBR had negative earnings in the past year.
NBR had a positive operating cash flow in the past year.
NBR had negative earnings in each of the past 5 years.
Each year in the past 5 years NBR had a positive operating cash flow.
NBR Yearly Net Income VS EBIT VS OCF VS FCFNBR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M -1B

1.2 Ratios

The Return On Assets of NBR (-2.76%) is worse than 73.02% of its industry peers.
NBR has a Return On Equity of -40.73%. This is amonst the worse of the industry: NBR underperforms 84.13% of its industry peers.
Looking at the Return On Invested Capital, with a value of 3.93%, NBR is doing worse than 69.84% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for NBR is below the industry average of 8.50%.
The 3 year average ROIC (3.54%) for NBR is below the current ROIC(3.93%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -2.76%
ROE -40.73%
ROIC 3.93%
ROA(3y)-4.38%
ROA(5y)-7.78%
ROE(3y)-88.52%
ROE(5y)-87.38%
ROIC(3y)3.54%
ROIC(5y)N/A
NBR Yearly ROA, ROE, ROICNBR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150

1.3 Margins

Looking at the Operating Margin, with a value of 7.43%, NBR is doing worse than 61.90% of the companies in the same industry.
With a decent Gross Margin value of 40.24%, NBR is doing good in the industry, outperforming 79.37% of the companies in the same industry.
NBR's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 7.43%
PM (TTM) N/A
GM 40.24%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.82%
GM growth 5Y2.06%
NBR Yearly Profit, Operating, Gross MarginsNBR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40

More info and screens

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so NBR is destroying value.
Compared to 1 year ago, NBR has more shares outstanding
Compared to 5 years ago, NBR has more shares outstanding
Compared to 1 year ago, NBR has an improved debt to assets ratio.
NBR Yearly Shares OutstandingNBR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
NBR Yearly Total Debt VS Total AssetsNBR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

NBR has an Altman-Z score of 0.34. This is a bad value and indicates that NBR is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.34, NBR is doing worse than 84.13% of the companies in the same industry.
A Debt/Equity ratio of 7.84 is on the high side and indicates that NBR has dependencies on debt financing.
NBR has a Debt to Equity ratio of 7.84. This is amonst the worse of the industry: NBR underperforms 90.48% of its industry peers.
Industry RankSector Rank
Debt/Equity 7.84
Debt/FCF N/A
Altman-Z 0.34
ROIC/WACC0.55
WACC7.15%
NBR Yearly LT Debt VS Equity VS FCFNBR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B

2.3 Liquidity

NBR has a Current Ratio of 1.80. This is a normal value and indicates that NBR is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.80, NBR is in line with its industry, outperforming 46.03% of the companies in the same industry.
A Quick Ratio of 1.62 indicates that NBR should not have too much problems paying its short term obligations.
The Quick ratio of NBR (1.62) is better than 61.90% of its industry peers.
Industry RankSector Rank
Current Ratio 1.8
Quick Ratio 1.62
NBR Yearly Current Assets VS Current LiabilitesNBR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

More info and screens

3

3. Growth

3.1 Past

NBR shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 6.37%.
The Revenue has decreased by -0.95% in the past year.
The Revenue has been decreasing by -0.76% on average over the past years.
EPS 1Y (TTM)6.37%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%148.02%
Revenue 1Y (TTM)-0.95%
Revenue growth 3Y13.25%
Revenue growth 5Y-0.76%
Sales Q2Q%-0.15%

3.2 Future

Based on estimates for the next years, NBR will show a very strong growth in Earnings Per Share. The EPS will grow by 31.89% on average per year.
The Revenue is expected to grow by 7.66% on average over the next years.
EPS Next Y76.77%
EPS Next 2Y37.55%
EPS Next 3Y31.89%
EPS Next 5YN/A
Revenue Next Year11.97%
Revenue Next 2Y8.7%
Revenue Next 3Y7.66%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
NBR Yearly Revenue VS EstimatesNBR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B
NBR Yearly EPS VS EstimatesNBR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 50 -50 -100

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

NBR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for NBR. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NBR Price Earnings VS Forward Price EarningsNBR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, NBR is valued cheaply inside the industry as 90.48% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 3.27
NBR Per share dataNBR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100 150

4.3 Compensation for Growth

A more expensive valuation may be justified as NBR's earnings are expected to grow with 31.89% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y37.55%
EPS Next 3Y31.89%

More info and screens

0

5. Dividend

5.1 Amount

NBR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

NABORS INDUSTRIES LTD

NYSE:NBR (6/20/2025, 8:04:00 PM)

After market: 32.61 0 (0%)

32.61

-1.16 (-3.44%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryEnergy Equipment & Services
Earnings (Last)04-29 2025-04-29/amc
Earnings (Next)07-21 2025-07-21/amc
Inst Owners77.21%
Inst Owner Change41.68%
Ins Owners3.96%
Ins Owner Change9.14%
Market Cap511.98M
Analysts50.67
Price Target38.32 (17.51%)
Short Float %12.42%
Short Ratio3.94
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.01
Dividend Growth(5Y)-73.53%
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-58.28%
Min EPS beat(2)-287.9%
Max EPS beat(2)171.33%
EPS beat(4)1
Avg EPS beat(4)-83.09%
Min EPS beat(4)-287.9%
Max EPS beat(4)171.33%
EPS beat(8)1
Avg EPS beat(8)-861.98%
EPS beat(12)3
Avg EPS beat(12)-667.87%
EPS beat(16)3
Avg EPS beat(16)-509.57%
Revenue beat(2)1
Avg Revenue beat(2)0.57%
Min Revenue beat(2)-1.08%
Max Revenue beat(2)2.22%
Revenue beat(4)1
Avg Revenue beat(4)-0.54%
Min Revenue beat(4)-1.71%
Max Revenue beat(4)2.22%
Revenue beat(8)2
Avg Revenue beat(8)-1.09%
Revenue beat(12)5
Avg Revenue beat(12)-0.41%
Revenue beat(16)8
Avg Revenue beat(16)0.02%
PT rev (1m)-21.49%
PT rev (3m)-45.02%
EPS NQ rev (1m)0%
EPS NQ rev (3m)35.48%
EPS NY rev (1m)0%
EPS NY rev (3m)-16.15%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)6.25%
Revenue NY rev (1m)-1.13%
Revenue NY rev (3m)6.53%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.17
P/FCF N/A
P/OCF 0.91
P/B 1.49
P/tB 1.49
EV/EBITDA 3.27
EPS(TTM)-12.93
EYN/A
EPS(NY)-2.12
Fwd EYN/A
FCF(TTM)-4.22
FCFYN/A
OCF(TTM)35.79
OCFY109.76%
SpS186.79
BVpS21.83
TBVpS21.83
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.76%
ROE -40.73%
ROCE 4.97%
ROIC 3.93%
ROICexc 4.34%
ROICexgc 4.34%
OM 7.43%
PM (TTM) N/A
GM 40.24%
FCFM N/A
ROA(3y)-4.38%
ROA(5y)-7.78%
ROE(3y)-88.52%
ROE(5y)-87.38%
ROIC(3y)3.54%
ROIC(5y)N/A
ROICexc(3y)4.37%
ROICexc(5y)N/A
ROICexgc(3y)4.37%
ROICexgc(5y)N/A
ROCE(3y)4.47%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.82%
GM growth 5Y2.06%
F-Score4
Asset Turnover0.58
Health
Industry RankSector Rank
Debt/Equity 7.84
Debt/FCF N/A
Debt/EBITDA 3.17
Cap/Depr 99.66%
Cap/Sales 21.42%
Interest Coverage 250
Cash Conversion 66.24%
Profit Quality N/A
Current Ratio 1.8
Quick Ratio 1.62
Altman-Z 0.34
F-Score4
WACC7.15%
ROIC/WACC0.55
Cap/Depr(3y)76.54%
Cap/Depr(5y)57.36%
Cap/Sales(3y)17.15%
Cap/Sales(5y)14.48%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)6.37%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%148.02%
EPS Next Y76.77%
EPS Next 2Y37.55%
EPS Next 3Y31.89%
EPS Next 5YN/A
Revenue 1Y (TTM)-0.95%
Revenue growth 3Y13.25%
Revenue growth 5Y-0.76%
Sales Q2Q%-0.15%
Revenue Next Year11.97%
Revenue Next 2Y8.7%
Revenue Next 3Y7.66%
Revenue Next 5YN/A
EBIT growth 1Y-16.5%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year277.65%
EBIT Next 3Y65.43%
EBIT Next 5YN/A
FCF growth 1Y-132.19%
FCF growth 3Y-58.66%
FCF growth 5Y-44.51%
OCF growth 1Y-8.45%
OCF growth 3Y10.68%
OCF growth 5Y-3.21%